Does EMPAGLIFLOZIN Cause Coronary arterial stent insertion? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Coronary arterial stent insertion have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.1% of all adverse event reports for EMPAGLIFLOZIN.
20
Reports of Coronary arterial stent insertion with EMPAGLIFLOZIN
0.1%
of all EMPAGLIFLOZIN reports
0
Deaths
9
Hospitalizations
How Dangerous Is Coronary arterial stent insertion From EMPAGLIFLOZIN?
Of the 20 reports, 9 (45.0%) required hospitalization.
Is Coronary arterial stent insertion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,644)
Fungal infection (1,941)
Blood glucose increased (1,797)
Euglycaemic diabetic ketoacidosis (1,769)
Weight decreased (1,661)
Urinary tract infection (1,439)
Ketoacidosis (1,411)
Dizziness (1,372)
Nausea (1,333)
Vomiting (1,201)
What Other Drugs Cause Coronary arterial stent insertion?
ROSIGLITAZONE (1,698)
METFORMIN\ROSIGLITAZONE (245)
ADALIMUMAB (175)
EVOLOCUMAB (109)
RANOLAZINE (95)
RISANKIZUMAB-RZAA (94)
AVANDIA (68)
ETANERCEPT (67)
IBRUTINIB (54)
UPADACITINIB (52)
Which EMPAGLIFLOZIN Alternatives Have Lower Coronary arterial stent insertion Risk?
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN vs EMSAM
EMPAGLIFLOZIN vs EMTRICITABINE